Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA AUROBINDO PHARMA CIPLA/
AUROBINDO PHARMA
 
P/E (TTM) x 32.2 23.0 140.3% View Chart
P/BV x 5.2 2.4 217.3% View Chart
Dividend Yield % 0.6 0.3 206.5%  

Financials

 CIPLA   AUROBINDO PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-23
AUROBINDO PHARMA
Mar-23
CIPLA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,185715 165.9%   
Low Rs852397 214.4%   
Sales per share (Unadj.) Rs281.9424.2 66.5%  
Earnings per share (Unadj.) Rs35.132.9 106.8%  
Cash flow per share (Unadj.) Rs49.754.1 91.7%  
Dividends per share (Unadj.) Rs8.503.00 283.3%  
Avg Dividend yield %0.80.5 154.6%  
Book value per share (Unadj.) Rs289.2458.1 63.1%  
Shares outstanding (eoy) m807.15585.94 137.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.61.3 275.7%   
Avg P/E ratio x29.016.9 171.6%  
P/CF ratio (eoy) x20.510.3 199.8%  
Price / Book Value ratio x3.51.2 290.2%  
Dividend payout %24.29.1 265.3%   
Avg Mkt Cap Rs m822,164325,753 252.4%   
No. of employees `000NANA-   
Total wages/salary Rs m38,30135,223 108.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,531248,554 91.5%  
Other income Rs m5,1212,906 176.2%   
Total revenues Rs m232,653251,460 92.5%   
Gross profit Rs m48,07937,070 129.7%  
Depreciation Rs m11,72112,446 94.2%   
Interest Rs m1,0951,405 78.0%   
Profit before tax Rs m40,38426,125 154.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,0296,849 175.6%   
Profit after tax Rs m28,35519,277 147.1%  
Gross profit margin %21.114.9 141.7%  
Effective tax rate %29.826.2 113.6%   
Net profit margin %12.57.8 160.7%  
BALANCE SHEET DATA
Current assets Rs m168,051214,599 78.3%   
Current liabilities Rs m50,333114,938 43.8%   
Net working cap to sales %51.740.1 129.0%  
Current ratio x3.31.9 178.8%  
Inventory Days Days7321 355.4%  
Debtors Days Days766 9.9%  
Net fixed assets Rs m117,318176,668 66.4%   
Share capital Rs m1,614586 275.5%   
"Free" reserves Rs m231,845267,813 86.6%   
Net worth Rs m233,460268,399 87.0%   
Long term debt Rs m06,190 0.0%   
Total assets Rs m290,067392,125 74.0%  
Interest coverage x37.919.6 193.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.6 123.8%   
Return on assets %10.25.3 192.5%  
Return on equity %12.17.2 169.1%  
Return on capital %17.810.0 177.2%  
Exports to sales %22.633.7 67.2%   
Imports to sales %8.915.3 58.0%   
Exports (fob) Rs m51,51683,703 61.5%   
Imports (cif) Rs m20,20238,060 53.1%   
Fx inflow Rs m64,28285,483 75.2%   
Fx outflow Rs m20,20241,447 48.7%   
Net fx Rs m44,08044,036 100.1%   
CASH FLOW
From Operations Rs m32,37723,868 135.7%  
From Investments Rs m-23,885-39,778 60.0%  
From Financial Activity Rs m-9,58318,144 -52.8%  
Net Cashflow Rs m-9682,298 -42.1%  

Share Holding

Indian Promoters % 13.4 48.8 27.5%  
Foreign collaborators % 20.0 3.1 652.8%  
Indian inst/Mut Fund % 50.0 41.3 121.0%  
FIIs % 25.7 20.7 124.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 48.2 138.1%  
Shareholders   425,731 241,944 176.0%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Aurobindo Pharma Share Price Performance

Period Cipla Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 1.94% 1.82% 1.18%
1-Month 1.25% 5.96% -0.75%
1-Year 68.02% 113.07% 61.82%
3-Year CAGR 22.53% 7.78% 18.16%
5-Year CAGR 23.24% 7.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of Cipla, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.